New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

FTXHvsFHLCETF Comparison

ETF 1
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-0.12%
VS
ETF 2
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
-0.12%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Fidelity MSCI Health Care Index ETF (FHLC) belong to the same industry segment: US Health Care. FTXH's top 1 sector exposures are Healthcare. In contrast, FHLC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.084% for FHLC. FTXH is up 23.32% year-to-date (YTD) with +$978M in YTD flows. FHLC performs worse with 8.92% YTD performance, and +$401M in YTD flows. Run a side-by-side ETF comparison of FTXH and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FTXH vs FHLC performance and flow charts

Performance

-2.00.02.04.06.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Cumulative Flows

0 M20 M40 M60 M80 M100 M120 MAug 10Aug 17Aug 24Aug 31Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/10/2026
1M3MYTD1Y3Y5Y
Perf.
FTXH
FHLC
+0.75%-1.57%
+14.81%+8.74%
+23.32%+8.92%
+46.70%+21.70%
+58.20%+33.56%
+66.91%+30.21%
Flows
FTXH
FHLC
+$41M+$129M
+$968M+$169M
+$978M+$401M
+$981M+$471M
+$973M-$285M
+$977M-$38M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FTXH
FHLC
+20.07%+18.29%
+17.74%+15.67%
+16.99%+14.71%
+16.34%+15.44%
Max drawdown
FTXH
FHLC
-5.34%-5.64%
-7.50%-10.35%
-19.32%-16.88%
-19.32%-17.78%
Max drawdown duration
FTXH
FHLC
16d23d
99d169d
393d435d
393d762d
Trading data

Create an account to view trading data

Join for free
FTXH
FHLC
Last sale
9/11/2026 at 1:30 PM
$40.47
$80.30
Previous close
09/10/2026
$40.52
$80.46
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FTXH
FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
FTXH
FHLC
Last price
$40.47
$80.30
1D performance
-0.13%
-0.20%
AuM$1.04 B$3.50 B
E/R0.6%0.084%
Characteristics
FTXH
FHLC
Management strategyPassivePassive
ProviderFirst TrustFidelity
BenchmarkNASDAQ US Smart Pharmaceuticals IndexMSCI USA IMI Health Care 25/50 Index
N° of holdings49329
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 20, 2016October 21, 2013
ESGNoNo
Advertisement
Exposure

Countries

FTXH
USA
95.79%
Other
4.21%
FHLC
USA
96.91%
Other
3.09%

Sectors

FTXH
Healthcare
99.86%
Other
0.14%
FHLC
Healthcare
97.59%
Other
2.41%

Diversification

FTXH

Total weight of top 15 holdings out of 15

66.98%
FHLC

Total weight of top 15 holdings out of 15

61.61%

Top 15 holdings

Data as of July 31, 2026
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
FHLC
Eli Lilly & Co.
13.80%
Johnson & Johnson
9.05%
AbbVie, Inc.
6.55%
UnitedHealth Group, Inc.
5.48%
Merck & Co., Inc.
4.59%
Thermo Fisher Scientific, Inc.
3.02%
Amgen, Inc.
2.98%
Abbott Laboratories
2.63%
Gilead Sciences, Inc.
2.35%
Pfizer Inc.
2.02%
CVS Health Corp.
1.96%
Bristol Myers Squibb Co.
1.83%
Intuitive Surgical, Inc.
1.81%
Danaher Corp.
1.79%
Vertex Pharmaceuticals, Inc.
1.76%
Frequently asked questions about FTXH and FHLC

How have the FTXH and FHLC ETFs performed in 2026?

As of September 10, 2026, FTXH is up 23.32% year-to-date (YTD), while FHLC has returned 8.92%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FTXH or FHLC?

Year-to-date, the FTXH ETF saw +$978M in flows, compared to +$401M for FHLC.

Which ETF is more volatile: FTXH or FHLC?

Over the past year, FTXH had a volatility of 17.74%, while FHLC experienced 15.67%.

Which ETF is bigger: FTXH or FHLC?

As of September 10, 2026, FTXH holds $1.04 B in assets under management (AUM), while FHLC manages $3.50 B.

What sectors do the FTXH and FHLC ETFs invest in?

FTXH leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the FTXH ETF and FHLC ETF?

FTXH top holdings include Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: FTXH or FHLC?

FTXH holds 49 securities with 66.98% of its assets in the top 15. FHLC has 333 securities and a top 15 weight of 61.61%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder